These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14638774)

  • 1. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
    Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
    Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
    Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
    mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
    Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
    Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
    Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A humanized monoclonal antibody targeting Staphylococcus aureus.
    Patti JM
    Vaccine; 2004 Dec; 22 Suppl 1():S39-43. PubMed ID: 15576200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
    Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
    J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
    Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
    mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of antigenic epitope of Staphylococcus aureus ClfA adhesin.
    Li Y; Liu YH; Li ZJ; Li YG; Liu MY; Liu LB; Wang XG; Wang XL; Suo J; Han WY
    Res Vet Sci; 2013 Jun; 94(3):490-5. PubMed ID: 23178048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characterization of antiserum after co-immunized with adhesins expressing ClfA, FnBPA-A and FnBPA-BCD of Staphylococus aureus].
    Jiang H; Su Y; Shen Y
    Wei Sheng Wu Xue Bao; 2015 Oct; 55(10):1343-9. PubMed ID: 26939463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
    Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
    PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
    Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
    Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
    Schennings T; Farnebo F; Szekely L; Flock JI
    APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus.
    Domanski PJ; Patel PR; Bayer AS; Zhang L; Hall AE; Syribeys PJ; Gorovits EL; Bryant D; Vernachio JH; Hutchins JT; Patti JM
    Infect Immun; 2005 Aug; 73(8):5229-32. PubMed ID: 16041045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
    Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
    Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.
    Arrecubieta C; Matsunaga I; Asai T; Naka Y; Deng MC; Lowy FD
    J Infect Dis; 2008 Aug; 198(4):571-5. PubMed ID: 18613794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies.
    Scarpa M; Piccinini R; Brun P; Grillo A; Palù G; Mengoli C; Daprà V; Castagliuolo I; Zecconi A
    J Dairy Res; 2010 May; 77(2):159-67. PubMed ID: 20030902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
    Ganesh VK; Liang X; Geoghegan JA; Cohen ALV; Venugopalan N; Foster TJ; Hook M
    EBioMedicine; 2016 Nov; 13():328-338. PubMed ID: 27789272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
    Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
    Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.